Company profile
Hurdle Knowledge Base
Get in touch with Hurdle.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
MA | Transaction MzQ0MDY3OTU1M2FkaXF6a2N4 | Paper/PDF filed
Published 01 Nov 2024 02:08
RP04SH01 | Transaction MzQ0MDY4NjIyMWFkaXF6a2N4
Published 25 Oct 2024 03:51
RESOLUTIONS | Transaction WUREVEhIRTBhZGlxemtjeA | Paper/PDF filed
Published 24 Oct 2024 07:07
SH01 | Transaction MzQzOTk1NzgxMGFkaXF6a2N4 | Paper/PDF filed
Published 26 Oct 2024 06:32
AP01 | Transaction MzQzOTgwMTc5NWFkaXF6a2N4
Published 16 Oct 2024 09:37
TM01 | Transaction MzQzOTgwMDY1MmFkaXF6a2N4
Published 16 Oct 2024 09:30
RP04CS01 | Transaction MzQzOTM2MjI3NmFkaXF6a2N4
Published 16 Oct 2024 07:43
SH01 | Transaction MzQzMzQzMjczNWFkaXF6a2N4
Published 16 Oct 2024 07:12
CS01 | Transaction MzQyMDY4MTQ4OGFkaXF6a2N4 | Paper/PDF filed
Published 17 Oct 2024 06:26
Company registered at Companies House
1 Mar 2026 to 31 Oct 2028
To develop an AI-enabled biomarker discovery engine, using multi-modal data, to address growing demand in the precision medicine market for disease risk prediction services.
